Can a patient immunized against varicella zoster (Varicella Zoster Virus) still develop shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient Immunized Against Varicella Zoster Still Get Shingles?

Yes, patients immunized against varicella zoster can still develop shingles, as the vaccine does not completely eliminate the risk of reactivation. 1

Mechanism of Shingles Development

The varicella-zoster virus (VZV) that causes chickenpox can establish latency in nerve ganglia after either:

  • Natural chickenpox infection
  • Vaccination with the varicella vaccine

This latent virus can later reactivate as shingles (herpes zoster) under certain conditions:

  • The varicella vaccine contains a weakened form of the virus that can establish latency in nerve ganglia, similar to wild-type virus 1
  • After primary infection (either natural or vaccine-strain), the virus becomes dormant in sensory nerve ganglia 2
  • Reactivation occurs when cellular immunity declines, leading to virus replication and the characteristic painful, vesicular rash of shingles 3

Risk of Shingles After Vaccination

Vaccine-Strain Shingles

  • It is possible, though rare, to develop shingles from the vaccine-strain virus 1
  • Studies suggest that the risk of developing vaccine-strain shingles is lower than the risk of developing shingles after natural chickenpox infection 4
  • In a study of leukemic children, the rate of herpes zoster after a mean 4.1 years of follow-up was only 2% in vaccine recipients compared to 15% in controls with a history of natural varicella 4

Long-term Risk

  • A long-term follow-up study of healthy adults who received the varicella vaccine 10-26 years prior found only 2 cases of herpes zoster among approximately 2,000 person-years of follow-up (rate of 1.00 case/1000 person-years) 5
  • This rate is similar to the background rate in the unvaccinated population during the pre-vaccine era, suggesting vaccination does not increase risk 5

Risk Factors for Shingles

Several factors increase the risk of shingles reactivation, regardless of whether the initial infection was from natural disease or vaccination:

  • Advanced age 1
  • Immunocompromised status 1
  • Acquisition of chickenpox during the first year of life 1
  • Decline in cellular immune response 3
  • Use of steroids 3
  • Malignancies 3
  • Hard physical work 3

Special Considerations

Immunocompromised Individuals

  • Severely immunocompromised patients should avoid live varicella vaccines 1
  • Immunocompromised individuals are at higher risk for more severe shingles with potential for cutaneous dissemination and visceral involvement 3
  • HIV-infected patients may experience shingles with involvement of multiple dermatomes and more frequent recurrences 3

Vaccination Recommendations

  • The CDC recommends shingles vaccination for adults 50 years and older, regardless of whether they recall having had chickenpox 1
  • For individuals known to be VZV-seronegative, some guidelines suggest immunization with 2 doses of varicella vaccine with an interval of 4 weeks 1
  • If you have active shingles, you should wait until the acute phase has resolved before getting vaccinated 1

Conclusion

While vaccination against varicella zoster significantly reduces the risk of developing shingles compared to natural infection, it does not provide complete protection. The vaccine-strain virus can establish latency and potentially reactivate later in life, although this occurs less frequently than with wild-type virus. Therefore, even immunized individuals should be aware of the possibility of developing shingles and should consider shingles vaccination when appropriate based on age and risk factors.

References

Guideline

Shingles Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Varicella zoster virus infection.

Nature reviews. Disease primers, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Risk of herpes zoster in adults immunized with varicella vaccine.

The Journal of infectious diseases, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.